IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
222.26
-3.72 (-1.65%)
At close: Dec 12, 2025, 4:00 PM EST
221.70
-0.56 (-0.25%)
After-hours: Dec 12, 2025, 7:23 PM EST
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $4.10B in the quarter ending September 30, 2025, with 5.24% growth. This brings the company's revenue in the last twelve months to $15.90B, up 3.85% year-over-year. In the year 2024, IQVIA Holdings had annual revenue of $15.41B with 2.81% growth.
Revenue (ttm)
$15.90B
Revenue Growth
+3.85%
P/S Ratio
2.43
Revenue / Employee
$180,727
Employees
88,000
Market Cap
37.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15.41B | 421.00M | 2.81% |
| Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
| Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
| Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
| Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
| Dec 31, 2019 | 11.09B | 676.00M | 6.49% |
| Dec 31, 2018 | 10.41B | 710.00M | 7.32% |
| Dec 31, 2017 | 9.70B | 2.89B | 42.36% |
| Dec 31, 2016 | 6.82B | 1.08B | 18.79% |
| Dec 31, 2015 | 5.74B | 277.00M | 5.07% |
| Dec 31, 2014 | 5.46B | 360.46M | 7.07% |
| Dec 31, 2013 | 5.10B | 234.03M | 4.81% |
| Dec 31, 2012 | 4.87B | 537.77M | 12.43% |
| Dec 31, 2011 | 4.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
IQV News
- 3 days ago - IQVIA: Increasingly Indispensable In Drug Development - Seeking Alpha
- 12 days ago - IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform - Business Wire
- 4 weeks ago - Oakmark Global Concentrated Strategy Q3 2025 Top Contributors And Detractors - Seeking Alpha
- 4 weeks ago - IQVIA Holdings Inc. (IQV) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Oakmark Concentrated Strategy: 6 Stocks That Raised Guidance And Drove Innovation - Seeking Alpha
- 5 weeks ago - Dr. William G. Kaelin Jr. joins IQVIA Board of Directors - Business Wire
- 6 weeks ago - IQVIA Holdings Inc. (IQV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - IQVIA narrows annual profit forecast amid continued research contract cancellations - Reuters